[Musashino University] Seminar: "The Present and Future of Medication Review: Based on the 2026 Revisions" to be held on Thursday, June 25

Musashino University will host an online postgraduate pharmacy education program on June 25, 2026, titled "The Present and Future of Medication Review." Featuring Yuya Iijima of Iijima Pharmacy, the seminar will cover the significance of medication review, which is now eligible for reimbursement under the 2026 revisions, and discuss future pharmacy practices.
healthNQ 48/100出典:PR Times

📋 Article Processing Timeline

  • 📰 Published: May 28, 2026 at 10:40
  • 🔍 Collected: June 1, 2026 at 01:11 (86h 31m after Published)
  • 🤖 AI Analyzed: June 1, 2026 at 01:12 (0 min after Collected)
Musashino University (Nishitokyo, Tokyo; President: Seiko Konishi) will hold an online postgraduate pharmacy education program titled "The Present and Future of Medication Review: Based on the 2026 Revisions" on Thursday, June 25. With medication review* becoming a reimbursable service under the 2026 revisions, its significance and implementation are being re-evaluated. In this lecture, we invite Mr. Yuya Iijima, founder of Iijima Pharmacy and executive director of the Ueda Pharmaceutical Association, to demonstrate the thought process from problem identification to intervention using cases of polypharmacy in the elderly. He will also examine the necessity of this practice within Japan's healthcare system from an international perspective. Furthermore, he will address challenges in sharing patient information, the redesign of pharmacy operations, and issues regarding quality assurance and education, while presenting future prospects. *A professional service where pharmacists comprehensively evaluate and optimize all medications taken by a patient (prescription drugs, OTC drugs, and supplements). Event Overview: Date: Thursday, June 25, 2026, 19:00–20:30. Venue: Online via Zoom Webinar. Target: Pharmacists, pharmacy students, etc. Capacity: 100 people. Participation Fee: 1,000 yen (Free for students).

FAQ

What is the status of medication review in Japan?

It is becoming a reimbursable service under the 2026 medical fee revisions, redefining the professional role of pharmacists.